| 26 |
Editorial Seeking definition. 2008
Malhi GS. · No affiliation provided · Bipolar Disord. · Pubmed #19594500 No free full text.
This publication has no abstract.
|
| 27 |
Editorial Focus on childhood and adolescent mental health. Predictors, criteria, and treatment response. 2009
Wagner KD. · No affiliation provided · J Clin Psychiatry. · Pubmed #19552868 No free full text.
This publication has no abstract.
|
| 28 |
Editorial The impact of lithium on bipolar disorder. 2009
Malhi GS. · No affiliation provided · Bipolar Disord. · Pubmed #19538680 No free full text.
This publication has no abstract.
|
| 29 |
Editorial Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder. free! 2009
Benabarre A, Castro P, Sánchez-Moreno J, Martinez-Arán A, Salamero M, Murru A, Franco C, Vieta E. · No affiliation provided · Actas Esp Psiquiatr. · Pubmed #19533426 links to free full text
Abstract: Introduction. Our aim was to evaluate treatment safety, tolerability, efficacy and compliance of long-acting injectable risperidone (LAIR) as maintenance treatment in a bipolar and schizoaffective inpatients sample with torpid course due to poor compliance to oral therapy. Methods. 22 inpatients, 14 with a diagnosis of bipolar disorder and 8 with a diagnosis of schizoaffective disorder, were included in this study. They were treated with LAIR, 1 dose every 14 days, and were evaluated for 40 weeks with the Young Mania Rating Scale (YMRS), Hamilton Scale for Depression (HAM-D), UKU-Side Effect Rating Scale and Clinical Global Impression Severity of Illness scales (CGI). Results. Average YMRS scores were reduced significantly from 10.5 at baseline interview to 2.5 at week 40 (p < 0.001). HAM-D and UKU scales did not reach a statistically significant reduction. CGI-S scores were reduced from 3.8 at baseline to 1.5 at week 40 (p < 0.001). Conclusions. LAIR could be an effective maintenance therapy for bipolar and schizoaffective patients with poor compliance to oral treatment. Key words: Bipolar disorder. Schizoaffective disorder. Risperidone. Long-acting antipsychotic. Adherence. Actas Esp Psiquiatr 2008;37(3):143-147.
|
| 30 |
Editorial Bipolar Disorder: an impossible diagnosis. free! 2009
Faravelli C, Gorini Amedei S, Scarpato MA, Faravelli L. · Department of Psychology, University of Florence, Firenze, Italy. · Clin Pract Epidemol Ment Health. · Pubmed #19531219 links to free full text
Abstract: ABSTRACT: Following the recent debates on the discrepancy between the predominant weight of bipolar disorder (BPD) in the clinical reality and its relatively low prevalence figures emerging from epidemiological surveys, the present paper contends the ability of current operational diagnostic system to properly detect the clinical entity of bipolar disorder.As an episode of mania/hypomania is the necessary requirement for a diagnosis of bipolar disorder to be made, in this editorial we maintain that: a) the most severe forms of mania, characterized by cloudy consciousness, mood incongruent delusions, and physical symptoms are likely to escape DSM IV criteria, that are shaped around hypomania or mild mania; b) the impossibility to diagnose mania when this occurs during antidepressant treatments impedes diagnosing those cases whose natural illness pattern is Depression followed by Mania (known as DMI pattern); c) given that approximately 50% of cases have their onset of BPD with affective episodes other than mania/hypomania any prevalence figure necessarily underestimates BPD; d) the sub-threshold forms of BPD, well described in the concept of Bipolar Spectrum, are beyond the possibility to be recognized using operational diagnoses in spite of their utmost clinical relevance.
|
| 31 |
Editorial Dissecting the many genetic faces of schizophrenia. 2009
Rujescu D, Collier DA. · · Epidemiol Psichiatr Soc. · Pubmed #19526738 No free full text.
Abstract: Abstract. Recent genome-wide association studies in schizophrenia have provided strongest evidence for association and this strengthened when the affected phenotype included bipolar disorder suggesting that genes may not always associate with operationalised diagnostic entities. Several further large Genome Wide Association (GWA) studies on schizophrenia are under way and identified and replicated further loci in well-powered cohorts. The last 2 years have also witnessed an explosion of interest in human Copy Number Variants (CNVs). Deletions recently identified in schizophrenia (1q21.1; 2p16.3; 15q11.2; 15q13.3) have also been most recently found in further neurodevelopmental diseases. Thus, a significant fraction of individuals with neurodevelopmental diseases including schizophrenia carry CNVs and many will be defined as "genomic disorders" in the coming years. These findings could represent a decisive step towards understanding the causes of this severe mental disorder as well as developing new potential treatments. There is new hope that these new avenues will help understanding the neurobiology of schizophrenia in more depth leading to the development of new innovative diagnostic tools and therapies as was the case after the discovery of rare APP and presenilin 1 and 2 mutations in Alzheimer's disease.
|
| 32 |
Editorial New hope for pharmacogenetic testing. 2009
Nurnberger JI. · No affiliation provided · Am J Psychiatry. · Pubmed #19487397 No free full text.
This publication has no abstract.
|
| 33 |
Editorial [Early onset bipolar disorders] 2009
Holtmann M. · No affiliation provided · Z Kinder Jugendpsychiatr Psychother. · Pubmed #19415600 No free full text.
This publication has no abstract.
|
| 34 |
Editorial New guidelines for bipolar disorders. 2009
Vieta E. · No affiliation provided · World J Biol Psychiatry. · Pubmed #19347774 No free full text.
This publication has no abstract.
|
| 35 |
Editorial Mood irritability - do we need to refine the diagnostic validity of oppositional defiant disorder and paediatric bipolar disorder? 2009
Banaschewski T. · No affiliation provided · J Child Psychol Psychiatry. · Pubmed #19309324 No free full text.
This publication has no abstract.
|
| 36 |
Editorial Recognizing parents' symptoms, obesity, and bipolar depression. 2008
Wagner KD. · · J Clin Psychiatry. · Pubmed #19203477 No free full text.
This publication has no abstract.
|
| 37 |
Editorial Mixed depression: the importance of rediscovering subtypes of mixed mood States. 2009
Schneck CD. · No affiliation provided · Am J Psychiatry. · Pubmed #19188286 No free full text.
This publication has no abstract.
|
| 38 |
Editorial Reversing criminalization. 2009
Lamb HR. · No affiliation provided · Am J Psychiatry. · Pubmed #19122011 No free full text.
This publication has no abstract.
|
| 39 |
Editorial Are structured interviews truly able to detect and diagnose Bipolar II disorders in epidemiological studies? The king is still nude! free! 2008
Carta MG, Hardoy MC, Fryers T. · Centro per la Terapia e la Ricerca in Salute Mentale, Dipartimento di Sanità Pubblica, Università di Cagliari, Cagliari, Italy. · Clin Pract Epidemol Ment Health. · Pubmed #19025594 links to free full text
Abstract: ABSTRACT: INTRODUCTION: A research commentary published in 2005 pointed out that the apparently low prevalence of Bipolar Disorder diagnosis as reported by epidemiological studies may be related to the under-estimate of bipolar disorder cases generally yielded by methodological instruments that are applied in such investigations. NEW DATA APPARENTLY CHALLENGE THIS NOTION: More recent publications have presented new results that apparently contradict the issues raised by the commentary, stating that the CIDI interview, which is used in the most important epidemiological studies is not only valid but highly reliable in identifying bipolar disorders. COMMENTARY: This paper analyzes the new data and concludes that they do not give a clear indication as to how reliably the CIDI can recognize undiagnosed bipolar disorder cases. Further research studies are needed on larger "negative" (to the CIDI) samples before the field will be persuaded that CIDI really does what it is supposed to do.
|
| 40 |
Editorial What is the best treatment for bipolar depression? free! 2008
Young LT. · No affiliation provided · J Psychiatry Neurosci. · Pubmed #18982170 links to free full text
This publication has no abstract.
|
| 41 |
Editorial [Cadet Rousslell syndrome, the rule of three according to Akiskal in the shadow of bipolar depression] 2008
Bourgeois ML. · No affiliation provided · Encephale. · Pubmed #18922231 No free full text.
This publication has no abstract.
|
| 42 |
Editorial Antidepressants in bipolar depression. 2008
Vieta E. · No affiliation provided · Acta Psychiatr Scand. · Pubmed #18855837 No free full text.
This publication has no abstract.
|
| 43 |
Editorial Focus on bipolar illness. free! 2008
Fountoulakis KN, Akiskal HS. · Third Department of Psychiatry, Aristotle University of Thessaloniki, Greece. · CNS Spectr. · Pubmed #18849895 links to free full text
This publication has no abstract.
|
| 44 |
Editorial New insights into bipolar disorder. free! 2008
Hollander E. · No affiliation provided · CNS Spectr. · Pubmed #18849891 links to free full text
This publication has no abstract.
|
| 45 |
Editorial New research perspectives in the treatment of bipolar disorder in older adults. 2008
Gyulai L, Young RC. · No affiliation provided · Bipolar Disord. · Pubmed #18837859 No free full text.
This publication has no abstract.
|
| 46 |
Editorial Bipolar drug development: are we getting closer to the real world? 2008
Calabrese JR, Kemp DE. · No affiliation provided · Am J Psychiatry. · Pubmed #18829876 No free full text.
This publication has no abstract.
|
| 47 |
Editorial Prescriptions for antipsychotic medications in schizophrenia. 2008
Moscarelli M, Rupp A. · No affiliation provided · J Ment Health Policy Econ. · Pubmed #18814385 No free full text.
This publication has no abstract.
|
| 48 |
Editorial [On bipolar disorder] 2008
Lôo H. · No affiliation provided · Encephale. · Pubmed #18707932 No free full text.
This publication has no abstract.
|
| 49 |
Editorial [Racing mania does not exist any more, manic-depressive psychosis even more so. How about schizophrenia?] 2007
Sechter D, Haffen E, Loo H. · No affiliation provided · Encephale. · Pubmed #18789780 No free full text.
This publication has no abstract.
|
| 50 |
Editorial The use of dopamine agonist in the treatment of restless legs syndrome: caution for practitioners and bipolar patients. 2008
Buckner AC. · No affiliation provided · South Med J. · Pubmed #18622349 No free full text.
This publication has no abstract.
|
Prior · Next |